This page uses frames, but your browser doesn't Capital Market, 2 weeks ago
Fulford India's director Mahendra Kumar Sharma resigns - Money Control, 2 weeks ago
The page you are looking for might have been removed, had its name changed, or is temporarily unavailable. Please try the following: Make sure that the Web site address displayed in the address bar of your browser is spelled and formatted ...SBICAP Securities, 2 weeks ago Fulford India directors resign Business Standard, 2 months ago Fulford India's additional director Caroline Litchfield resigns Money Control, 2 months ago
which raised 40.25 crore from its promoters by allotting seven lakh shares at 575 apiece in 2006, informed the exchanges that it has utilised only 2.72 crore till now. The funds were raised to provide the company with capital to strengthen its position in the ...Business Line, 2 months ago
MSD, a trade name of Merck & Co., Inc. and Cipla have entered into an India specific strategic partnership. Under the partnership, Cipla will have a non-exclusive license to market, promote and distribute MSD's raltegravir 400mg tablet, under a ...PharmaBiz, 1 month ago Cipla to market HIV drug in India Deccan Chronicle, 1 month ago Cipla to market MSD's HIV drug 'raltegravir' in India Business Standard India, 1 month ago Cipla to market US-based MSD's HIV drug raltegravir in India Business Standard India, 1 month ago
on your WebpageAdd Widget >Get your members hooked!